Eli Lilly Method Patent For Gemzar Found Invalid
A federal judge has ruled that one of Eli Lilly & Co.'s patents for cancer treatment Gemzar is invalid, in a dispute with Sun Pharmaceutical Industries Ltd. over a proposed generic...To view the full article, register now.
Already a subscriber? Click here to view full article